The Role of Early Molecular Response in the Management of Chronic Phase CML

Current Hematologic Malignancy Reports - United States
doi 10.1007/s11899-017-0375-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC